‌

US Patent 9308257 Protein formulation

Patent 9308257 was granted and assigned to MedImmune, LLC on April, 2016 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors

Is a

Patent

Patent attributes

Current Assignee

MedImmune, LLC

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

93082570

Patent Inventor Names

Ambarish Shah0

Monika S. Sharma, Sr.0

Scott Hammond0

Date of Patent

April 12, 2016

Patent Application Number

127447450

Date Filed

November 26, 2008

Patent Citations Received

‌

US Patent 12006366 Methods and compositions for preventing type 1 diabetes

‌

US Patent 11866498 Bispecific antigen-binding molecules and methods of use

‌

US Patent 11918650 Pharmaceutical composition comprising bispecific antibody constructs for improved storage and administration

Patent Primary Examiner

‌

Yunsoo Kim

Patent abstract

The present invention provides stable lyophilized formulations of bispecific antibodies or fragments thereof.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 9308257 Protein formulation

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API